A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples